Relationship between hepatic venous patency and atrial caval shunting curative effects in patients with type Ⅱ Budd-Chiari syndrome

doi:10.3877/cma.j.issn.2095-655X.2014.04.010

Abstract

Abstract:

Objective

To investigate the relationship between atrial caval shunting (ACS) curative effects for type Ⅱ Budd-Chiari syndrome (BCS) and hepatic venous outflow patency.

Methods

Two hundred and nine patients undergoing atrial caval shunting for type Ⅱ Budd-Chiari syndrome were retrospectively analyzed and divided into hepatic venous outflow patent group (group A) and stenotic group (group B). The preoperative and postoperative clinical symptoms were observed respectively.χ²-test, t-test and Kaplan-Meier test were used to analyze the changes of portal free pressure (PFP) and inferior vena cava pressure (IVCP) before and after artificial blood vessels (ABV) opening, incidence of significant postoperative complications and ABV patency rates.

Results

The clinical symptoms of one hundred and eighty-three BCS patients were disappeared or alleviated.Severe complications occurred in six cases, with one case died from pulmonary embolism.The PFP reduction of group A was significantly lower than that of group B[(2.09±0.33)kPa, (2.97±0.41)kPa; (t=15.48, P<0.05)], and portal hypertension syndromes in group A alleviated more greatly than that of group B. ABV patency was 80.0% for five years after surgery and group A was superior to group B(χ²=9.32, P<0.05).

Conclusions

ACS treatment for hepatic venous outflow in patent with type Ⅱ BCS patients could decrease PFP and IVCP simultaneously, with lower postoperative complications and higher ABV patency rates.

Key words: Budd-Chiari syndrome, Portasystemic shunt, surgical, Treatment outcome

Liancai Wang, Chunhui Gao, Haibo Yu, Senmao Mu, Deyu Li. Relationship between hepatic venous patency and atrial caval shunting curative effects in patients with type Ⅱ Budd-Chiari syndrome[J]. Chinese Journal of Diagnostics(Electronic Edition), 2014, 02(04): 285-287.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhzdxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-655X.2014.04.010

https://zhzdxdzzz.cma-cmc.com.cn/EN/Y2014/V02/I04/285

Figures/Tables 2

References 12

[1]	Dang XW, Xu PQ, Ma XX，et al.Surgical treatment of Budd-Chiari syndrome：analysis of 221 cases[J]．Hepatobiliary Pancreat Dis Int，2011，10(4):435-438.
[2]	于振海．布加综合征的诊治[M]．北京：人民卫生出版社，2007：5-6.
[3]	Yamamoto S, Yokoyama Y, Takeshige K，et al.Budd-Chiari syndrome with obstruction of the inferior vena cava[J]．Gastroenterology，1968，54(6):1070-1084.
[4]	Orloff MJ, Daily PO, Orloff SL，et al.A 27-year experience with surgical treatment of Budd-Chiari syndrome[J]．Ann Surg，2000，232(3):340-352.
[5]	Rinckenbach S, Chakfé N, Beaufigeau M，et al.Surgical treatment of a Budd-Chiari syndrome secondary to hepatic inferior vena cava agenesia[J]．J Cardiovasc Surg (Torino)，2002，43(5): 665-669.
[6]	Okuda K．Inferior vena cava thrombosis at its hepatic portion (obliterative hepatocavopathy)[J]．Semin Liver Dis，2002，22(1):15-26.
[7]	徐斌，周颖奇，景在平，等．布加综合征腔内分型治疗与旁路转流术的对比性研究[J]．中华外科杂志，2002，40(6):423-426.
[8]	汪忠镐．布-加综合征的治疗对策和对置放支架及肝移植指征的探讨[J]．临床外科杂志，2007，15(3):147-149.
[9]	潘祥林，王鸿利．诊断学的任务与发展方向[J/CD]．中华诊断学电子杂志，2013，1(1):8-9.
[10]	Ohara I, Ouchi H, Takahashi K．A Bypass Operation for Occlusion of the Hepatic Inferior Vena Cava[J]．Surg Gynecol Obstet，1963，117:151-155.
[11]	汪忠镐，李春民．肠-腔-房转流术治疗Ⅱ型布-加综合征(附1例报道)[J]．临床肝胆病杂志，2011，27(2):196-197.
[12]	Bachet JB, Condat B, Hagege H，et al.Long-term portosystemic shunt patency as a determinant of outcome in Budd-Chiari syndrome[J]．J Hepatol，2007，46(1):60-68.

组别	例数	IVCP		t值	P值	PFP		t值	P值
组别	例数	术前	术后2周	t值	P值	术前	术后2周	t值	P值
A组	159	2.87±0.49	1.59±0.52	0.32	<0.05	3.45±0.58	2.09±0.33	0.43	<0.05
B组	50	2.99±0.56	1.51±0.55	0.27	<0.05	3.39±0.43	2.97±0.41	7.46	>0.05
t值	1.46	0.94	?	?	0.68	15.48	?	?	?
P值	>0.05	>0.05	?	?	>0.05	<0.05	?	?	?

组别	例数	IVCP		t值	P值	PFP		t值	P值
组别	例数	术前	术后2周	t值	P值	术前	术后2周	t值	P值
A组	159	2.87±0.49	1.59±0.52	0.32	<0.05	3.45±0.58	2.09±0.33	0.43	<0.05
B组	50	2.99±0.56	1.51±0.55	0.27	<0.05	3.39±0.43	2.97±0.41	7.46	>0.05
t值	1.46	0.94	?	?	0.68	15.48	?	?	?
P值	>0.05	>0.05	?	?	>0.05	<0.05	?	?	?

[1]	Zhengwen Xu, Zhen Li, Zhenyang Hou, Changzheng Su, Biao Zhu. Platelet rich plasma combined with bone grafting for treatment of early non-traumatic osteonecrosis of femoral head [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2023, 17(06): 773-779.
[2]	Hongyu Wang. Application value of fixed and mobile platform prostheses in total knee arthroplasty [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2023, 17(06): 871-876.
[3]	Shanwu Li, Yongjie Ye, Bing Wang, Ziyi Wang, Yi Yin, Guanjun Sun, Dagang Zhang. Early efficacy comparison of open wedge high tibial osteotomy and unicompartmental knee arthroplasty [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2023, 17(06): 882-888.
[4]	Zeyong Wang, Jian Qin. Effect of white blood cell content on platelet-rich plasma treatment of motor system injuries [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2023, 17(05): 684-688.
[5]	Zhaolong Yan, Zhenbin Zhang, Guangxing Li, Zhang Zhao, Yeyong Zhang, Luxu Yin, Shufeng Li. Early results and influencing factors of high tibial osteotomy in treatment of knee osteoarthritis [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2023, 17(04): 492-499.
[6]	Cong Wu, Lun Liu, Quanzhong Jia. Short-term efficacy and influencing factors of primary total hip arthroplasty in elderly femoral neck fracture [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2023, 17(02): 283-287.
[7]	Longfei Zhang, Yong Gao, Yigang Zhang, Chaowen Yu, Delang Liu, Ya Liu, Shiyuan Chen. Expression and clinical significance of Apolipoprotein B, sex hormone binding globulin and tissue inhibitors of metalloproteinase 1 in Budd-Chiari syndrome of inferior vena cava in northern Anhui [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(04): 252-256.
[8]	Haitao Zhang, Chanjuan Kang, Jingjie Zhai. Effect of pancreatic duct stent implantation in the treatment of acute biliary pancreatitis [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 654-657.
[9]	Yao Chen, Boqun Xu, Zhihui Gao. Efficacy and safety of modified intermediate upper approach radical resection in the treatment of thyroid cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 619-622.
[10]	Xiong Li, Yongkuan Cao. Clinical study of ISR with different distal incisal margin distances after neoadjuvant therapy for locally advanced rectal [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(04): 443-446.
[11]	Shusen Feng, Dongcheng Zhang, Qi Guo, Haolu Zhang, Kuo Chen. Clinical effect of laparoscopic appendectomy on acute appendicitis and its influence on inflammatory factors [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(04): 447-450.
[12]	Xiaopei Bu, Bing Liu, Jianghua Zhang, Chen Zhao, Jinjiang Zhang, Peizhong Shang. Hysterorectal fistula：a case report [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(04): 469-470.
[13]	Fengjie Wang, Liguang Wang, Shan Liao, Ying Liu, Rongdang Fu, Huanwei Chen. Safety and efficacy of laparoscopic right hemihepatectomy for hepatocellular carcinoma [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(05): 517-522.
[14]	Shilong Guo, Xiao Yang, Huanhuan Hu, Liang Yang, Wenfu Zhou, Kuiwu Cong, Yusheng Zhang, Yingfeng Li. Efficacy and safety of ERCP in minimally invasive treatment for biliary and pancreatic diseases [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(02): 216-220.
[15]	Qingjin Zeng, Liwen Zhao, Yuxuan Wu, Xuqi He, Lanxia Zhang, Xuan Yu, Na He, Rongqin Zheng, Kai Li. Clinical efficacy of ultrasound-guided percutaneous thermal ablation for malignant liver tumors adjacent to the heart [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(01): 49-54.

Please choose a citation manager

Content to export